About Agappe
Agappe is a Healthcare company based in Ernakulam (India) founded in 1994. In-vitro diagnostic reagents and equipment are manufactured and distributed. Agappe has raised $7.83 million across 1 funding round from investors including Sycamore Partners and Konark Capital Partners. The company has 1,298 employees. Agappe was last valued at $33.77 million in May 2015. Its website agappe.com draws about 46 thousand monthly visits. Its Indian entity Agappe Diagnostics Limited reported revenue of ₹521 Cr. Agappe offers products and services including Diagnostic Solutions. Its focus areas include Diversified Diagnostics and Tests.
Company details
Agappe was founded in 1994 in Ernakulam, India, and operates in the in-vitro diagnostics sector. Over 300 distributors support its presence across Asia, Africa, and America. Revenue reached Rs 93.5 crore in FY15. An equipment manufacturing unit is maintained, with another being established near Kochi. Products cover biochemistry, immunochemistry, serology, blood grouping, coagulation, hematology, system agents, urinalysis, and microbiology. Clinical laboratories, hospitals, and pathologists are served as primary customers.
- Headquarters Ernakulam, India
- Employees 1,298
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Website agappe.com
- Social LinkedIn Facebook
- Legal Name Agappe Diagnostics Limited
- Date of Incorporation 18 Jun, 1998
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹521 Cr
FY 2025 · +17% YoY
- Net Profit₹31.28 Cr
FY 2025 · 6% margin
- EBITDA₹73.51 Cr
FY 2025 · 14% margin
- Total Equity Funding$7.83M (USD)
in 1 rounds
- Latest Funding Round$7.83M (USD), Private Equity Round
May 2015
- InvestorsSycamore Partners
& 1 more
- Employee Count1,298
Associated legal entities of Agappe
Agappe operates through Agappe Diagnostics Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Agappe Diagnostics Limited CIN U24239MH1998PLC115413 | Active | 18 Jun 1998 | Mumbai, Maharashtra | ₹521 Cr | 929 | 10 | View details |
Products & Services of Agappe
Agappe offers a comprehensive portfolio of products and services, including Diagnostic Solutions.
Offers tools and services for laboratory and hospital testing needs.
Funding Insights of Agappe
Agappe has successfully raised a total of $7.83M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $7.83 million completed in May 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.83M
- Total Rounds 1
- Last Round Private Equity Round — $7.83M
- First Round $7.83M
(May 2015)
- Investors Count 2
All 1 funding rounds of Agappe with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2015 | $7.83M | Private Equity Round | $33.77M | Konark Capital Partners, Sycamore Partners | – |
| Date | Valuation | Stage |
|---|---|---|
| May 2015 | $33.77M | •••••••• |
Last known valuation $33.77M (May 2015). 2 investors in total: 2 institutional.
Investors in Agappe
Agappe has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Sycamore Partners and Konark Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward retail and consumer sectors. | 2011 | sycamorepartners.com | New York, United States | |
Limited information is available on core activities. | konarkpartners.com | Ebene City, Mauritius |
Investor details for Agappe
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Agappe Diagnostics Limited (Agappe)
Agappe Diagnostics Limited is the primary company behind Agappe. The board of Agappe Diagnostics Limited currently have 9 directors; the longest-serving is Sangeeta Joseph, appointed in 2006. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sangeeta Joseph DIN 00684485 | Whole-time director | 15 Dec 2006 | 19 yrs 10 mo | Agappe Diagnostics Limited |
| Meena Thomas DIN 01665997 | Whole-time director | 31 May 2007 | 19 yrs 5 mo | Agappe Diagnostics Limited |
| Thomas John DIN 00138331 | Managing Director | 01 Jun 2012 | 14 yrs 5 mo | Agappe Diagnostics Limited |
| Joseph John DIN 07926271 | Director | 26 Sep 2017 | 9 yrs 1 mo | Agappe Diagnostics Limited |
| Mary Baby Meleth DIN 01882175 | Whole-time director | 01 Jan 2021 | 5 yrs 10 mo | Agappe Diagnostics Limited |
| Rhema Elizabeth Thomas DIN 09140518 | Whole-time director | 10 May 2021 | 5 yrs 6 mo | Agappe Diagnostics Limited |
| Joseph Vadakkekara Antony DIN 00181554 | Director | 30 Jun 2021 | 5 yrs 4 mo | Agappe Diagnostics Limited |
| Thomas Jacob Kalappila DIN 00812892 | Director | 18 Apr 2022 | 4 yrs 6 mo | Agappe Diagnostics Limited |
| Damodaran Madhavi Vasudevan DIN 02948429 | Whole-time director | 06 Jun 2023 | 3 yrs 5 mo | Agappe Diagnostics Limited |
People of Agappe
92 people are tracked at Agappe (19 in leadership, 73 in team); the tracked headcount is 1,298.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership | |
Majesh Mammen | Zonal Sales Head | Leadership |
Jiby Kuriakose | Business Unit Head | Leadership |
Suryakanta Nanda | Associate Vice President | Leadership |
Jaison Varghese | General Manager - Product Evaluation Reagents | Leadership |
Saji Daniel Mathew | Vice President - Institutional Business | Leadership |
Sanjay Chhabra | Zonal Business Head(sales) | Leadership |
Bijoy C J | Associate Vice President | Leadership |
Rajesh Kv | Zonal Sales Head | Leadership |
Biju Philip | Vice President - Sales | Leadership |
Sreevisakh K L | Associate Vice President | Leadership |
Vikram Tandon | Business Head (executive Vice President) - India | Leadership |
Mohammed Salim Soudagar | Regional Business Head | Leadership |
Bhaskar Malladi | Head - Strategy | Leadership |
Juby Jacob | Group General Manager Finance And Accounts | Leadership |
Vijay Kumar Nalla | Channel Partner | Leadership |
Navin Chainani | Sr Vice President- Specialty Diagnostics | Leadership |
Raj Kishore | Sales Head-north India | Leadership |
Jayesh Kumar | Head - Digital Marketing Communications | Leadership |
Dil Sabu | Zonal Service Manager | Team |
72 more people are available in the full profile.
Complete people profiles for Agappe
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Agappe
Figures of Agappe Diagnostics Limited, the primary company behind Agappe, for FY 2025. Revenue was ₹521 Cr (+17% year on year). Net profit was ₹31.28 Cr (6% margin). EBITDA was ₹73.51 Cr (14% margin). Revenue has grown at a compounded annual rate of +6% over three years and +20% over five years.
- ₹521 CrRevenue · FY 2025 · +17% YoY
- ₹31.28 CrNet profit · 6% margin
- ₹73.51 CrEBITDA · 14% margin
- ₹6.13 CrPaid-up capital
- 929Employees (provident fund records)
- +6%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Agappe Diagnostics Limited are on its company page.
Detailed financial statements for Agappe
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Agappe
3 dated milestones of Agappe across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Agappe is founded.
- Funding First funding round of $7.8M.
- Milestone Reaches Minicorn status.
Web traffic of Agappe
The website of Agappe (agappe.com) receives about 46.2K visits a month.
- Monthly visits46.2K
▼ 0.6% vs previous month
Websites whose visitors overlap most with Agappe. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| atlas-medical.com | 100% | 19.7K | #1,416,805 | View details | |
| medlabsgroup.com | 97% | #670,332 | View details | ||
| tulipgroup.com | 95% | 10.7K | #2,081,130 | View details | |
| fortressdiagnostics.com | 92% | #3,973,986 | View details | ||
kimssunshine.co.in | kimssunshine.co.in | 91% | #853,402 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Agappe
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Agappe
Complete news archive for Agappe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Agappe
Agappe was founded in 1994 and raised its 1st funding round 21 years after it was founded.
Agappe is headquartered in Ernakulam, India. It is registered at Ernakulam, Kerala, India.
Agappe is a funded company, having raised a total of $7.83M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $7.83M, raised on May 2015.
Agappe has 1,298 employees.
The primary company behind Agappe, Agappe Diagnostics Limited, reported revenue of ₹521 Cr for FY 2025, up 17% year on year.
Agappe was founded in 1994 in Ernakulam, India, and operates in the in-vitro diagnostics sector. Over 300 distributors support its presence across Asia, Africa, and America. Revenue reached Rs 93.5 crore in FY15. An equipment manufacturing unit is maintained, with another being established near Kochi. Products cover biochemistry, immunochemistry, serology, blood grouping, coagulation, hematology, system agents, urinalysis, and microbiology. Clinical laboratories, hospitals, and pathologists are served as primary customers.
Agappe offers Diagnostic Solutions.
Agappe has 2 investors. Key investors include Sycamore Partners, and Konark Capital Partners.
The valuation of Agappe is $33.77M as of May 2015.
Agappe operates through Agappe Diagnostics Limited.
The legal entities of Agappe currently have 10 directors, including Mary Baby Meleth, Rhema Elizabeth Thomas, Meena Thomas and others.